
Significant insider buying activity was reported for Biodesix (BDSX) and Anterix (ATEX), signaling executive confidence. At Biodesix, Jack W. Schuler purchased 18,373 shares for $111,425 at $6.06 per share, building on prior investments, with the stock up 8.5% on Friday and his recent buy already gaining 20.7%. Concurrently, Anterix CEO Scott A. Lang acquired 4,650 shares for $98,952 at $21.28, his first such transaction in a year, as ATEX traded up 7.8% and his purchase showed a 9.3% gain. These transactions highlight bullish sentiment from key insiders, leading to immediate positive market reactions for both companies.
Significant insider buying activity signals strong executive confidence at Biodesix (BDSX) and Anterix (ATEX). At Biodesix, insider Jack W. Schuler acquired 18,373 shares for $111,425 at a price of $6.06 per share. This purchase is particularly noteworthy as it follows five other buys over the past twelve months, bringing his total recent investment to $3.31M and indicating sustained conviction. The market reacted favorably, with BDSX trading up 8.5% and Schuler's latest purchase already showing an unrealized gain of 20.7% based on the day's high. Concurrently, Anterix CEO Scott A. Lang made his first insider purchase in a year, acquiring 4,650 shares for $98,952 at $21.28 each. A CEO's first open-market buy is a potent signal of a positive outlook, which was met with a 7.8% rise in ATEX's share price and an immediate 9.3% paper gain for the executive. Both events underscore a bullish thesis from individuals with privileged information, which has been immediately validated by positive market momentum.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment